| |
Company Financials: Asia Pacific Breweries Limited
Datamonitor
Scope / / *Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation / / *Provides key ratios / / *Includes information on revenue distribution by business segments and geographies / /
|
2011 |
75,00$ |
| |
Mylan Inc.: PharmaVitae Profile
Datamonitor
Introduction
The analysis examines the historical and forecast performance for Mylan in the generic prescription pharmaceutical sector. The profile encompasses global company str
|
2010 |
5.700,00$ |
| |
Shire plc: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Shire in the prescription pharmaceutical sector. The profile encompasses global company strategy, p
|
2010 |
5.700,00$ |
| |
Abbott Laboratories: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Abbott in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Bristol-Myers Squibb Co.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Bristol-Myers Squibb in the prescription pharmaceutical sector. The profile encompasses global comp
|
2010 |
5.700,00$ |
| |
GlaxoSmithKline plc: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for GlaxoSmithKline in the prescription pharmaceutical sector. The profile encompasses global company s
|
2010 |
5.700,00$ |
| |
Otsuka Pharmaceutical Co., Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Otsuka in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Warner-Chilcott Plc: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Warner Chilcott in the prescription pharmaceutical sector. The profile encompasses global company s
|
2010 |
5.700,00$ |
| |
Apotex Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Apotex in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Merck & Co., Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Merck & Co. in the prescription pharmaceutical sector. The profile encompasses global company strat
|
2010 |
5.700,00$ |
| |
Sanofi-Aventis: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Sanofi-Aventis in the prescription pharmaceutical sector. The profile encompasses global company st
|
2010 |
5.700,00$ |
| |
Boehringer Ingelheim GmbH: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Boehringer Ingelheim in the prescription pharmaceutical sector. The profile encompasses global comp
|
2010 |
5.700,00$ |
| |
Forest Laboratories Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Forest in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Novo Nordisk A/S: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Novo Nordisk in the prescription pharmaceutical sector. The profile encompasses global company stra
|
2010 |
5.700,00$ |
| |
UCB S.A.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for UCB in the prescription pharmaceutical sector. The profile encompasses global company strategy, por
|
2010 |
5.700,00$ |
| |
Allergan Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Allergan in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
5.700,00$ |
| |
Cephalon Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Cephalon in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
11.400,00$ |
| |
Johnson & Johnson: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Johnson & Johnson in the prescription pharmaceutical sector. The profile encompasses global company
|
2010 |
5.700,00$ |
| |
Baxter International Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Baxter in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Daiichi Sankyo Co., Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Daiichi Sankyo in the prescription pharmaceutical sector. The profile encompasses global company st
|
2010 |
5.700,00$ |
| |
Novartis AG: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Novartis in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
5.700,00$ |
| |
Teva Pharma. Industries Ltd: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Teva in the prescription pharmaceutical sector. The profile encompasses global company strategy, po
|
2010 |
5.700,00$ |
| |
Alcon Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Alcon in the prescription pharmaceutical sector. The profile encompasses global company strategy, p
|
2010 |
5.700,00$ |
| |
Celgene Corporation: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Celgene in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
H. Lundbeck A/S: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy
|
2010 |
5.700,00$ |
| |
Pfizer Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Watson Pharmaceuticals Inc.: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Watson in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
AstraZeneca plc: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for AstraZeneca in the prescription pharmaceutical sector. The profile encompasses global company strat
|
2010 |
5.700,00$ |
| |
CSL Limited: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for CSL in the prescription pharmaceutical sector. The profile encompasses global company strategy, por
|
2010 |
5.700,00$ |
| |
Sandoz International GmbH: PharmaVitae Profile
Datamonitor
Introduction
This analysis examines the historical and forecast performance for Sandoz in the prescription pharmaceutical sector. The profile encompasses global company strategy,
|
2010 |
5.700,00$ |
| |
Visa Europe Limited - Strategic SWOT Analysis Review
GlobalData
Visa Europe Limited - Strategic SWOT Analysis Review
Summary
Visa Europe Limited (Visa Europe) is a payment solutions company, wholly owned, controlled, and operated by more than
|
2012 |
125,00$ |
| |
Temasek Holdings (Private) Limited - Strategic SWOT Analysis Review
GlobalData
Temasek Holdings (Private) Limited - Strategic SWOT Analysis Review
Summary
Temasek Holdings (Private) Limited (Temasek) is an Asian investment company. The company offers growth
|
2012 |
125,00$ |
| |
Hong Leong Financial Group Berhad (HLFG) - Financial and Strategic SWOT Analysis Review
GlobalData
Hong Leong Financial Group Berhad (HLFG) - Financial and Strategic SWOT Analysis Review
Summary
Hong Leong Financial Group Berhad (HLFG) is a Malaysian investment holding company
|
2012 |
125,00$ |
| |
State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review
GlobalData
State Atomic Energy Corporation Rosatom - Strategic SWOT Analysis Review
Summary
State Atomic Energy Corporation "Rosatom" (ROSATOM) runs all nuclear assets of the Russian Feder
|
2012 |
125,00$ |
| |
Santam Limited (SNT) - Financial and Strategic SWOT Analysis Review
GlobalData
Santam Limited (SNT) - Financial and Strategic SWOT Analysis Review
Summary
Santam Limited (Santam) is a leading short-term insurance provider., Santam operates as a subsidiary o
|
2012 |
125,00$ |
| |
Spencer’s Retail Limited - Strategic SWOT Analysis Review
GlobalData
Spencer’s Retail Limited - Strategic SWOT Analysis Review
Summary
Spencer’s Retail Limited (Spencer’s) is a multi-format retailer engaged in the operation of hypermarket and conv
|
2012 |
125,00$ |
| |
Companhia Anonima de Administracion y Fomento Electrico (Cadafe) - Strategic SWOT Analysis Review
GlobalData
Companhia Anonima de Administracion y Fomento Electrico (Cadafe) - Strategic SWOT Analysis Review
Summary
Companhia Anonima de Administracion y Fomento Electrico (Cadafe) is an e
|
2012 |
125,00$ |
| |
Nidec Corporation (6594) - Financial and Strategic SWOT Analysis Review
GlobalData
Nidec Corporation (6594) - Financial and Strategic SWOT Analysis Review
Summary
Nidec Corporation (Nidec) carries out the manufacture of electric motors, electronic machinery and
|
2012 |
125,00$ |
| |
Converted Organics Inc. (COIN) - Financial and Strategic SWOT Analysis Review
GlobalData
Converted Organics Inc. (COIN) - Financial and Strategic SWOT Analysis Review
Summary
Converted Organics Inc. (Converted Organics) is a US-based natural fertilizers company. It o
|
2012 |
125,00$ |
| |
Nampak Limited (NPK) - Financial and Strategic SWOT Analysis Review
GlobalData
Nampak Limited (NPK) - Financial and Strategic SWOT Analysis Review
Summary
Nampak Limited (Nampak) is one of the largest packaging companies in South Africa. The company along w
|
2012 |
125,00$ |
| |
Turbo Power Systems Inc. (TPS) - Financial and Strategic SWOT Analysis Review
GlobalData
Turbo Power Systems Inc. (TPS) - Financial and Strategic SWOT Analysis Review
Summary
Turbo Power Systems Inc. (TPS) is engaged in designing and manufacturing of high-speed perma
|
2012 |
125,00$ |
| |
Takara Holdings Inc. (2531) - Financial and Strategic SWOT Analysis Review
GlobalData
Takara Holdings Inc. (2531) - Financial and Strategic SWOT Analysis Review
Summary
Takara Holdings Inc. (Takara) is a holding group engaged in the manufacturing and marketing of
|
2012 |
125,00$ |
| |
Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review
GlobalData
Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review
Summary
Premier Foods plc (Premier Foods) is principally engaged in the manufacture and supply of food prod
|
2012 |
125,00$ |
| |
Bayou City Exploration, Inc. (BYCX) - Financial and Strategic SWOT Analysis Review
GlobalData
Bayou City Exploration, Inc. (BYCX) - Financial and Strategic SWOT Analysis Review
Summary
Bayou City Exploration, Inc. (Bayou City) is an onshore upstream oil and gas company.
|
2012 |
125,00$ |
| |
Newmont Mining Corporation (NEM) - Financial and Strategic SWOT Analysis Review
GlobalData
Newmont Mining Corporation (NEM) - Financial and Strategic SWOT Analysis Review
Summary
Newmont Mining Corporation (Newmont) is engaged in the production of gold from its propert
|
2012 |
125,00$ |
| |
M.D.C. Holdings, Inc. (MDC) - Financial and Strategic SWOT Analysis Review
GlobalData
M.D.C. Holdings, Inc. (MDC) - Financial and Strategic SWOT Analysis Review
Summary
M.D.C. Holdings, Inc. (MDC), through its subsidiaries, provides homebuilding and financial serv
|
2012 |
125,00$ |
| |
Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review
GlobalData
Eli Lilly and Company (LLY) - Financial and Strategic SWOT Analysis Review
Summary
Eli Lilly and Company (Lilly) is a pharmaceutical company, which carries out the design, develo
|
2012 |
125,00$ |
| |
Suncor Energy Inc. (SU) - Financial and Strategic SWOT Analysis Review
GlobalData
Suncor Energy Inc. (SU) - Financial and Strategic SWOT Analysis Review
Summary
Suncor Energy Inc. (Suncor) is an integrated energy company based in Canada. Suncor is engaged in t
|
2012 |
125,00$ |
| |
BAVARIA, S.A. - Strategic SWOT Analysis Review
GlobalData
BAVARIA, S.A. - Strategic SWOT Analysis Review
Summary
BAVARIA, S.A. (Bavaria) formerly known as Grupo Empresarial Bavaria is engaged in the production and distribution of bevera
|
2012 |
125,00$ |
| |
